Ausgabe 5/2024
Inhalt (21 Artikel)
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review
Jessica R. Allegretti, Jessica H. Brady, Ann Wicker, Mark Latymer, Alvin Wells
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar
Norman Gaylis, Charlotte Both, Lena Lemke, Oliver von Richter, Paul Yamauchi
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review
Mustafa Khasraw, Priyanka Yalamanchili, Anu Santhanagopal, Chuntao Wu, Maribel Salas, Jie Meng, Maha Karnoub, Stephen Esker, Enriqueta Felip
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor
Marc Evans, Mansoor Husain, Ayush Srivastava, Kamal Kant Mangla, Anja Birk Kuhlman, Ildiko Lingvay
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis
Larry Culpepper, Ashley Martin, Nadia Nabulsi, Mousam Parikh
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause
Aki Shiozawa, Shayna Mancuso, Christopher Young, Jennifer Friderici, Summer Tran, Helen M. Trenz
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis
Lidan Huang, Hong Liu, Xue Zou, Jiawang Ding, Song Tao
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience
Paimann Nawrozi, Thomas Ratschiller, Wolfgang Schimetta, Gregor Gierlinger, Markus Pirklbauer, Hannes Müller, Andreas Zierer
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data
Brian G. M. Durie, Shaji K. Kumar, Eric M. Ammann, Alex Z. Fu, Shuchita Kaila, Annette Lam, Saad Z. Usmani, Thierry Facon
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
Gilles Salles, Jenny M. H. Chen, Ina Zhang, Fabio Kerbauy, James J. Wu, Sally W. Wade, Ana Nunes, Chaoling Feng, Ioana Kloos, Weimin Peng, Julia T. Snider, Dylan Maciel, Keith Chan, Sam Keeping, Bijal Shah
Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital
Xiaomin Xing, Haijun Qu, Longyuan Wang, Xiaojia Hao, Yalan Zhong, Fanbo Jing
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
Angela T. H. Kwan, Ziji Guo, Felicia Ceban, Gia Han Le, Sabrina Wong, Kayla M. Teopiz, Taeho Greg Rhee, Roger Ho, Joshua D. Di Vincenzo, Sebastian Badulescu, Shakila Meshkat, Bing Cao, Joshua D. Rosenblat, Giacomo d’Andrea, Donovan A. Dev, Lee Phan, Mehala Subramaniapillai, Roger S. McIntyre
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids
Peter T. Daley-Yates, Bhumika Aggarwal, Maximilian Plank
Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes
Rose J. Hart, Fareen Hassan, Sarah Alulis, Karl W. Patterson, Jennifer Norma Barthelmes, Jennifer H. Boer, Dawn Lee
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study
Jiat Ling Poon, Louise OHara, Helen Kendal, Kate Sully, Margaret Guy, Helena Bradley, Chloe Tolley, Brad Mason
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study
Christopher J. Patriquin, Andrija Bogdanovic, Morag Griffin, Richard J. Kelly, Jaroslaw P. Maciejewski, Brian Mulherin, Régis Peffault de Latour, Alexander Röth, Veena Selvaratnam, Jeffrey Szer, Mohammed Al-Adhami, Regina Horneff, Lisa Tan, Michael Yeh, Jens Panse
Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research
Stella Karantzoulis, Karli Heuer, Nicole Sparling, Brian Meltzer, Megan Teynor
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Awad Alshahrani, Naji Kholaif, Mutaz Al-Khnifsawi, Hawazen Zarif, Moeber Mahzari
Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis
Claire Watkins, Tatiana Paulo, Christian Bührer, Nancy M. Holekamp, Marloes Bagijn
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Benjamin Chastek, Adam Carrera, Christina Landis, Daniel Snyder, Laleh Abedinzadeh, Tim Bancroft, Jeffrey Nesheim, Michael Kennelly, David Staskin